#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital myopathy Endometrial cancer recurrent Malignant neoplasm of choroid X-linked lymphoproliferative syndrome Hepatoblastoma Neuroendocrine tumour of the lung Still's disease Selective polysaccharide antibody deficiency Palmar-plantar erythrodysaesthesia syndrome Peritoneal neoplasm Hereditary spastic paraplegia Renal disorder Postprandial hypoglycaemia Systemic candida Neuroendocrine tumour More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Basic Information Fragile X syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease VEXAS syndrome – Life with Disease Arterial tortuosity syndrome – Trials in Disease Hereditary neuropathic amyloidosis – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Skin angiosarcoma – Basic Information Skin angiosarcoma Alternating hemiplegia of childhood – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gabapentin Magnesium Oxide, Light Ethinylestradiol Omp10 Capmatinib Alnus Glutinosa Pollen Jnj-81241459 Dazukibart Favezelimab Bt-001 ANGIOTENSIN II Bosentan Gsk4527226 Lutetium (177Lu) Edotreotide ZELENECTIDE PEVEDOTIN Rbl007.2 Tpst-1120 Poltreg-T1D Anifrolumab Pegcetacoplan More therapies…

    Learn about Your Condition

    Pigmentary glaucoma Traumatic pain Hypotonia Lip and/or oral cavity cancer Inflammation Anaemia of chronic disease Cervical dysplasia Cleft lip and palate Ocular myasthenia Post-traumatic stress disorder Pancreatic carcinoma Aphthous ulcer Alveolar bone defect Haemorrhage Papillary thyroid cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Breast cancer

  • Study on Using Perflubutane for Sentinel Node Detection in Patients with Breast Cancer, Melanoma, or Head and Neck Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Head and neck cancer
    • Breast cancer
    Investigated Drugs:
    • Perflubutane
    The Netherlands

  • Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Malignant melanoma
    • Endometrial cancer
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study of JK06 for Patients with Advanced or Metastatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Adenosquamous cell lung cancer
    • Bladder cancer
    Investigated Drugs:
    • Jk06
    Belgium Spain

  • Study on the Effect of Prasterone on Genitourinary Syndrome in Postmenopausal Women with a History of Breast Cancer or Undergoing Anti-Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Genitourinary syndrome of menopause
    • Breast cancer
    Investigated Drugs:
    • Prasterone
    Italy

  • Study of Fertility Preservation Using Tamoxifen, Follitropin Beta, Cetrorelix and Choriogonadotropin Alfa in Women with Breast Cancer Before Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cetrorelix
    • Follitropin Beta
    • Choriogonadotropin Alfa
    France

  • Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    • Endometrial cancer
    • Fallopian tube cancer
    Investigated Drugs:
    • Olaparib
    Belgium Bulgaria Czechia France Germany Hungary +6
Previous Page
1 … 4 5 6 7 8 … 28
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!